Rebamipide-d4
Rebamipide-d4 is deuterium labeled Rebamipide. Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner[1].
Product Specifications
CAS Number
1219409-06-9
Product Name Alternative
OPC12759-d4; Proamipide-d4
UNSPSC
12352005
Hazard Statement
H301, H312, H330, H410
Target
COX; Isotope-Labeled Compounds; Prostaglandin Receptor
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Purity
99.0
Solubility
10 mM in DMSO
Smiles
OC(C(NC(C1=C([2H])C([2H])=C(Cl)C([2H])=C1[2H])=O)CC(C2=CC=CC=C2N3)=CC3=O)=O
Molecular Formula
C19H11D4ClN2O4
Molecular Weight
374.81
Precautions
H301, H312, H330, H410
References & Citations
[1]Sun WH, et al. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther. 2000 Nov;295 (2) :447-52.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
EP
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
30484124 3x 1.0µg DNA
MRPL40 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
44151121 3x 1.0µg DNA
SLC35F5 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details YGC02927-01 50 mg
2-[2- (4-Fluorophenyl) -1,3-thiazol-4-yl]ethan-1-amine dihydrochloride
Sign In for Pricing
View Details